Araştırma Makalesi

Evaluation of Triglyceride-Glucose Index as a Marker of Insulin Resistance in Non-Obese Young Women with Polycystic Ovary Syndrome

Cilt: 36 Sayı: 2026 11 Haziran 2026
PDF İndir
EN TR

Evaluation of Triglyceride-Glucose Index as a Marker of Insulin Resistance in Non-Obese Young Women with Polycystic Ovary Syndrome

Öz

Aim: Polycystic ovary syndrome (PCOS) is frequently associated with insulin resistance (IR), even in non-obese women. The triglyceride-glucose index (TGI) has recently emerged as a potential surrogate marker of IR. This study aimed to evaluate the utility of TGI as a marker for IR in non-obese young women with PCOS.
Materials and Methods:  In this retrospective study, 84 non-obese women aged 18–35 years newly diagnosed with PCOS were compared with 73 age-matched healthy controls. TGI was calculated using fasting plasma triglycerides level and fasting plasma glucose, and values were compared between groups. The ROC curve was used to calculate the optimal TGI cut-off value and the sensitivity and specificity of this value between the PCOS and control groups.
Results: No significant difference was detected between the groups in terms of age (p =0.084). TGI value was found to be 8.26 [8.14, 8.42] in the control group and 8.52 [8.46, 8.75] in the PCOS group (p<0.001). Optimal ROC cutoff value of TGI between control and PCOS groups was calculated as 8.44 with 86% sensitivity and 86% specificity (AUC: 0.904 P<0.001 95% CI 0.856-0.951).
Conclusion: TGI levels are significantly higher in young, non-obese women with PCOS, suggesting that it could be a simple, cost-effective and reliable indicator of insulin resistance in this group. These findings emphasise the importance of assessing metabolic risk in non-obese patients with PCOS and indicate a possible application for TGI in routine clinical screening.

Anahtar Kelimeler

insulin resistance, metabolic risk, non-obese, Polycystic ovary syndrome, triglyceride-glucose index

Kaynakça

  1. 1. Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 2016;106:6-15.
  2. 2. Wang J, Wu D, Guo H, Li M. Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. Life Sci 2019;236:116940.
  3. 3. Paschou SA, Polyzos SA, Anagnostis P, Goulis DG, Kanaka-Gantenbein C, Lambrinoudaki I et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Endocrine 2020;67:1-8.
  4. 4. Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. Metabolism 2018;86:33-43.
  5. 5. Baptiste CG, Battista MC, Trottier A, Baillargeon JP. Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol 2010;122:42-52.
  6. 6. Al-Jefout M, Alnawaiseh N, Al-Qtaitat A. Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes. Sci Rep 2017;7:5339.
  7. 7. Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 2008;6:299-304.
  8. 8. Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol 2014;13:146.
  9. 9. Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, González-Nava V, Díaz González-Colmenero A, Solis RC et al. Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review. Int J Endocrinol 2020;2020:4678526.
  10. 10. Chamroonkiadtikun P, Ananchaisarp T, Wanichanon W. The triglyceride-glucose index, a predictor of type 2 diabetes development: A retrospective cohort study. Prim Care Diabetes 2020;14:161-167.

Kaynak Göster

APA
Gündoğan, K., Ahmadkhanlı, A., & Acar, A. (2026). Evaluation of Triglyceride-Glucose Index as a Marker of Insulin Resistance in Non-Obese Young Women with Polycystic Ovary Syndrome. Genel Tıp Dergisi, 36(2026), 1-5. https://doi.org/10.54005/geneltip.1756939
AMA
1.Gündoğan K, Ahmadkhanlı A, Acar A. Evaluation of Triglyceride-Glucose Index as a Marker of Insulin Resistance in Non-Obese Young Women with Polycystic Ovary Syndrome. Genel Tıp Derg. 2026;36(2026):1-5. doi:10.54005/geneltip.1756939
Chicago
Gündoğan, Kübra, Asmar Ahmadkhanlı, ve Ali Acar. 2026. “Evaluation of Triglyceride-Glucose Index as a Marker of Insulin Resistance in Non-Obese Young Women with Polycystic Ovary Syndrome”. Genel Tıp Dergisi 36 (2026): 1-5. https://doi.org/10.54005/geneltip.1756939.
EndNote
Gündoğan K, Ahmadkhanlı A, Acar A (01 Haziran 2026) Evaluation of Triglyceride-Glucose Index as a Marker of Insulin Resistance in Non-Obese Young Women with Polycystic Ovary Syndrome. Genel Tıp Dergisi 36 2026 1–5.
IEEE
[1]K. Gündoğan, A. Ahmadkhanlı, ve A. Acar, “Evaluation of Triglyceride-Glucose Index as a Marker of Insulin Resistance in Non-Obese Young Women with Polycystic Ovary Syndrome”, Genel Tıp Derg, c. 36, sy 2026, ss. 1–5, Haz. 2026, doi: 10.54005/geneltip.1756939.
ISNAD
Gündoğan, Kübra - Ahmadkhanlı, Asmar - Acar, Ali. “Evaluation of Triglyceride-Glucose Index as a Marker of Insulin Resistance in Non-Obese Young Women with Polycystic Ovary Syndrome”. Genel Tıp Dergisi 36/2026 (01 Haziran 2026): 1-5. https://doi.org/10.54005/geneltip.1756939.
JAMA
1.Gündoğan K, Ahmadkhanlı A, Acar A. Evaluation of Triglyceride-Glucose Index as a Marker of Insulin Resistance in Non-Obese Young Women with Polycystic Ovary Syndrome. Genel Tıp Derg. 2026;36:1–5.
MLA
Gündoğan, Kübra, vd. “Evaluation of Triglyceride-Glucose Index as a Marker of Insulin Resistance in Non-Obese Young Women with Polycystic Ovary Syndrome”. Genel Tıp Dergisi, c. 36, sy 2026, Haziran 2026, ss. 1-5, doi:10.54005/geneltip.1756939.
Vancouver
1.Kübra Gündoğan, Asmar Ahmadkhanlı, Ali Acar. Evaluation of Triglyceride-Glucose Index as a Marker of Insulin Resistance in Non-Obese Young Women with Polycystic Ovary Syndrome. Genel Tıp Derg. 01 Haziran 2026;36(2026):1-5. doi:10.54005/geneltip.1756939